With just a few days into the New Year, stock market analysts and pundits are making their predictions for 2026. But how good ...
The SEC has accused an investment banker and a trading ring of exploiting healthcare M&A intelligence and fake pharma news to ...
The Pulse series has firmly established itself as a bang-for-buck favourite since its inception in 2017 and that looks to be ...
In today’s Pharma Pulse, the FDA issues two high-stakes priority vouchers for cholesterol and cancer therapies, GSK leverages ...